Regulatory Strategies for Combination Products: Navigating Complex Pathways | #regulatory services

Regulatory Strategies for Combination Products: Navigating Complex Pathways

Combination products, which integrate drugs, devices, and/or biological products, have revolutionized healthcare by offering innovative therapeutic solutions. However, their unique nature presents significant Regulatory challenges. This comprehensive guide explores the intricate landscape

Managing High-Volume Regulatory Submissions | #regulatory services

Managing High-Volume Regulatory Submissions

The life sciences industry operates in a highly regulated environment, where compliance with global health authorities such as the FDA, EMA, and MHRA is critical. Regulatory publishing and submissions teams are often tasked with managing large-scale filings, including drug approvals, renew

What Life Sciences Companies Need to Know about Japan’s Transition to eCTD 4.0 | #regulatory services

What Life Sciences Companies Need to Know about Japan’s Transition to eCTD 4.0

The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan is set to fully implement eCTD 4.0, marking a significant shift in electronic submission standards for pharmaceutical and medical device applications. This transition aligns with global regulatory advancements, ensuring more st

Labeling Strategies for FDCs: Balancing Multiple Drug Information | #regulatory services

Labeling Strategies for FDCs: Balancing Multiple Drug Information

Fixed-dose combination (FDC) products, which combine two or more active pharmaceutical ingredients in a single dosage form, have become increasingly popular due to their potential to improve patient compliance, simplify dosing schedules, and prevent dose dividing. However, effectively labe

How to Conduct Effective Label Comparison for Generic Drugs | #regulatory services

How to Conduct Effective Label Comparison for Generic Drugs

Generic drugs are vital in making healthcare affordable and accessible, serving as cost-effective alternatives to brand-name medications. However, ensuring their equivalence to branded drugs requires meticulous label comparison. This process is essential for healthcare professionals, pharm